Clinical Trials Directory

Trials / Unknown

UnknownNCT02535273

The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia

The Effect of Dexmedetomidine Subsidiary Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia:A Randomized, Double Blind Controlled Trial

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
212 (estimated)
Sponsor
Tang-Du Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Evaluate safety and efficacy of dexmedetomidine in minimally invasive spine surgery under local anesthesia sedation.Explore the appropriate concentration of dexmedetomidine, whether or not can reduce the amount of local anesthetics.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes.
DRUGLidocainelocal anesthesia:0.67% lidocaine local anesthesia layer by layer to the periosteum at the puncture site,Establish puncture channel, injection 5ml 0.67% lidocaine into the vertebral body through the catheter, and observe 5-10min before operation
DRUGLow-dose Dexmedetomidinemaintenance dose:Intravenous infusion of dexmedetomidine 0.3 μg/kg/min until the end of surgery
DRUGModerate-dose Dexmedetomidinemaintenance dose:Intravenous infusion of dexmedetomidine 0.5 μg/kg/min until the end of surgery
DRUGHigh-dose Dexmedetomidinemaintenance dose:Intravenous infusion of dexmedetomidine 0.7 μg/kg/min until the end of surgery
DRUGnormal salineIntravenous injection normal saline equal quantity,completed within 10 minutes. Intravenous infusion of normal saline 0.125 μg/kg/min until the end of surgery

Timeline

Start date
2015-09-01
Primary completion
2016-08-01
Completion
2016-09-01
First posted
2015-08-28
Last updated
2015-08-28

Source: ClinicalTrials.gov record NCT02535273. Inclusion in this directory is not an endorsement.